Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%

Trials by Status

completed240%
terminated120%
active_not_recruiting120%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruiting

Evolution of Oropharyngeal and Rectal Microbiota After Severe Traumatic Brain Injury

NCT03965611
recruiting

Longitudinal Preschool Wheeze Biomarker Study

NCT06237660
completed

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

NCT04408014
completed

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

NCT02352389
terminated

A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom

NCT01292213

Clinical Trials (5)

Showing 5 of 5 trials
NCT03965611

Evolution of Oropharyngeal and Rectal Microbiota After Severe Traumatic Brain Injury

Active Not Recruiting
NCT06237660

Longitudinal Preschool Wheeze Biomarker Study

Recruiting
NCT04408014

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Completed
NCT02352389

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Completed
NCT01292213

A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5